ARTICLE | Company News
Shire Pharmaceuticals Group plc management update
November 4, 2002 8:00 AM UTC
Shire Pharmaceuticals Group plc (LSE:SHP; SHPGY), Basingstoke, U.K. Business: Neurological, Cancer Departing: Rolf Stahel as CEO and executive director ...